Primary headaches - treatment today and tomorrow
نویسندگان
چکیده
منابع مشابه
Treatment of cutaneous lymphomas: today and tomorrow.
There exist many skin-directed and systemic immunomodulating or cytotoxic treatment options for primary cutaneous T- and B-cell lymphomas. However, especially in advanced stages conventional therapies only end in a transient remission without curative results unable to prolong overall survival. Over the last twenty years the high need of new therapeutic strategies resulted in the development of...
متن کاملAlzheimer's Disease: Yesterday, Today, Tomorrow
Alzheimer's disease is the most common and well - known cause of dementia, as a progressive, irreversible brain disorder that affects cognitive function, personality, thought, perception and behaviour. Alzheimer's disease is the fourth leading cause of death in western countries. Interesting to know that this disease was unknown in medical community till 100 years ago and had no name. Dr. Alois...
متن کاملPhotovoltaics today and tomorrow.
In the next several decades it is expected that the United States and the rest of the nations of the world will greatly expand their consumption of electricity. But many questions will accompany this expansion: Can we build enough generating capacity? Do we have enough energy resources? Can we accommodate centralized and dispersed needs, large and small applications, and the diverse requirement...
متن کاملVaccination today and tomorrow.
The vaccines against infectious diseases in use today are, with few exceptions, prepared from the causal agents themselves, either by inactivating them with a chemical such as formaldehyde or by attenuating them so that they grow and thus evoke an immune response in the natural host but cause no disease. These empirical approaches have produced many highly successful vaccines. Increasing knowle...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurologie pro praxi
سال: 2018
ISSN: 1213-1814,1803-5280
DOI: 10.36290/neu.2018.050